Acadia Healthcare Welcomes Dr. Patrice A. Harris, MD, MA as Independent Director
October 26 2023 - 4:05PM
Business Wire
Former President of the American Medical
Association and Board-Certified Psychiatrist Adds Significant
Mental Health and Substance Abuse Clinical Expertise
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced
that Dr. Patrice A. Harris, MD, MA has been appointed to the
Company’s Board of Directors effective October 26, 2023.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20231026253607/en/
Acadia Healthcare welcomes Dr. Patrice A.
Harris, MD, MA as Independent Director (Photo: Business Wire)
Dr. Harris is board-certified in psychiatry and has diverse
experience as a private practicing physician, public health
director and patient advocate. Active in organized medicine
throughout her 25-year career, Dr. Harris previously served on the
Board of Trustees of the American Psychiatric Association (APA) and
was an APA delegate to the American Medical Association (AMA). In
2019, Dr. Harris was elected as the 174th President of the AMA, the
first African American woman to ever hold the position in which she
served until 2020. She also previously served as Chair of the AMA’s
Opioid Task Force and on AMA work groups devoted to health
information technology, sustainable growth rate and private
contracting. Currently, Dr. Harris continues in private practice
and is Co-Founder and Chief Executive Officer of eMed Digital
Healthcare, a digital healthcare company she co-founded in
2020.
Dr. Harris’ medical leadership positions at the state level
include serving on the Board and as President of the Georgia
Psychiatric Physicians Association and on the Medical Association
of Georgia’s Council on Legislation, its Committee on Constitution
and Bylaws, and its Membership Task Force. She was also the
founding president of the Georgia Psychiatry Political Action
Committee. As past director of Health Services for Fulton County,
Ga., which includes Atlanta, Dr. Harris was the county’s Chief
Health Officer, overseeing all county health-related programs and
functions, including a wide range of public safety, behavioral
health, and primary care treatment and prevention services.
She is a Visiting Professor at Columbia University Vagelos
College of Physicians and Surgeons, Department of Psychiatry, an
Adjunct Professor of Psychiatry and Behavioral Sciences at Emory
University School of Medicine and an Adjunct Clinical Assistant
Professor in Psychiatry and Behavioral Sciences at Morehouse School
of Medicine. Dr. Harris is a Fellow of the APA. Dr. Harris received
her B.A. in Psychology, M.A. in Counseling Psychology and M.D. from
West Virginia University.
“Patrice is among the most respected leaders in healthcare
policy and practice, and she brings deep clinical expertise in
areas core to Acadia’s business, including mental health and
substance abuse,” said Reeve B. Waud, Chairman of the Board of
Acadia Healthcare. “We know that Patrice's experience and work
integrating public health, behavioral health and primary care
services will be valuable to Acadia’s success and our continued
growth as the leading behavioral healthcare services provider.”
"We are proud of the significant progress we are making in
executing our strategy through our defined growth pathways,
extending our market reach to more communities and adding service
lines to new states,” said Chris Hunter, Chief Executive Officer of
Acadia. “We are delighted to welcome Patrice to the Board and
expect her deep clinical experience to help us build on this
momentum.”
“I greatly admire Acadia’s commitment to setting the standard
for excellence in the treatment of mental health and addiction
concerns. I look forward to working closely with the Board to
ensure Acadia delivers on this mission, which has never been more
critical to communities across the country. I am excited to be part
of Acadia’s growth and the quality care it provides,” said Dr.
Harris.
About Acadia
Acadia is a leading provider of behavioral healthcare services
across the United States. As of September 30, 2023, Acadia operated
a network of 253 behavioral healthcare facilities with
approximately 11,100 beds in 39 states and Puerto Rico. With
approximately 23,000 employees serving more than 75,000 patients
daily, Acadia is the largest stand-alone behavioral healthcare
company in the U.S. Acadia provides behavioral healthcare services
to its patients in a variety of settings, including inpatient
psychiatric hospitals, specialty treatment facilities, residential
treatment centers and outpatient clinics.
Forward-Looking Information
This press release contains forward-looking statements.
Generally, words such as “may,” “will,” “should,” “could,”
“anticipate,” “expect,” “intend,” “estimate,” “plan,” “continue,”
and “believe” or the negative of or other variation on these and
other similar expressions identify forward-looking statements.
These forward-looking statements are made only as of the date of
this press release. We do not undertake to update or revise the
forward-looking statements, whether as a result of new information,
future events or otherwise. Forward-looking statements are based on
current expectations and involve risks and uncertainties and our
future results could differ significantly from those expressed or
implied by our forward-looking statements. Factors that may cause
actual results to differ materially include, without limitation,
(i) potential difficulties in successfully integrating the
operations of acquired facilities or realizing the expected
benefits and synergies of our facility expansions, acquisitions,
joint ventures and de novo transactions; (ii) Acadia’s ability to
add beds, expand services, enhance marketing programs and improve
efficiencies at its facilities; (iii) potential reductions in
payments received by Acadia from government and commercial payors;
(iv) the occurrence of patient incidents, governmental
investigations, litigation (including without limitation the three
pending lawsuits in New Mexico) and adverse regulatory actions,
which could adversely affect the price of our common stock and
result in substantial payments and incremental regulatory burdens;
(v) the risk that Acadia may not generate sufficient cash from
operations to service its debt and meet its working capital and
capital expenditure requirements; (vi) potential disruptions to our
information technology systems or a cybersecurity incident; and
(vii) potential operating difficulties, including, without
limitation, disruption to the U.S. economy and financial markets;
reduced admissions and patient volumes; increased costs relating to
labor, supply chain and other expenditures; changes in competition
and client preferences; and general economic or industry conditions
that may prevent Acadia from realizing the expected benefits of its
business strategies. These factors and others are more fully
described in Acadia’s periodic reports and other filings with the
SEC.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231026253607/en/
Gretchen Hommrich Vice President, Investor Relations (615)
861-6000
Acadia Healthcare (NASDAQ:ACHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Acadia Healthcare (NASDAQ:ACHC)
Historical Stock Chart
From Jul 2023 to Jul 2024